Centene公司因据称的金融错报面临投资者诉讼,导致其股票暴跌。 Centene Corp faces investor lawsuits over alleged financial misstatements, causing its stock to plummet.

Centene Corporation正受到证券律师事务所的调查,因为该公司的入学率和发病率可能误导投资者。 Centene Corporation is under investigation by securities law firms for potentially misleading investors about its enrollment and morbidity rates. 该公司撤回了2025年指南,导致股票价格下降40%。 The company withdrew its 2025 guidance, leading to a 40% drop in its stock price. 诉讼指控称,Centene公司就其财务前景和入学率作了虚假陈述。 Lawsuits allege that Centene made false statements about its financial prospects and enrollment rates. 《重建更好法案》还可能削减医疗补助资金，影响 Centene 的收入，因为医疗补助占其收入的 62%。 The Build Back Better Act could also cut Medicaid funding, affecting Centene's revenue, as Medicaid makes up 62% of its revenue. 律师事务所正在鼓励损失超过75 000美元的受影响投资者与它们联系,以争取可能的恢复。 Law firms are encouraging affected investors with losses over $75,000 to contact them for potential recovery.